A novel defense mechanism that is activated on amyloid-β insult to mediate cell survival: Role of SGK1-STAT1/STAT2 signaling

Cell Death and Differentiation

Volumn 16, Issue 11, 2009, Pages 1515-1529

  Hsu, W L ^a   Chiu, T H ^a   Tai, D J C ^b   Ma, Y L ^b   Lee, E H Y ^b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN MCL 1; SERINE; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; SMALL INTERFERING RNA; STAT1 PROTEIN; STAT2 PROTEIN; TYROSINE;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; GENETIC TRANSFECTION; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; UPREGULATION;

AMINO ACID SUBSTITUTION; AMYLOID BETA-PROTEIN; ANIMALS; BASE SEQUENCE; CELL SURVIVAL; IMMEDIATE-EARLY PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 3; MOLECULAR SEQUENCE DATA; PC12 CELLS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT2 TRANSCRIPTION FACTOR; TRANSFECTION;

RATTUS;

EID: 70350011890     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2009.91     Document Type: Article

References (45)

1. De Strooper B, Annaert W. Proteolytic processing and cell biological functions of the amyloid precursor protein. J Cell Sci 2000; 113: 1857-1870.
2. Butterfield DA, Drake J, Pocernich C, Castegna A. Evidence of oxidative damage in Alzheimer's disease brain: Central role for amyloid beta-peptide. Trends Mol Med 2001; 7: 548-554.
3. Dickson DW. Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: Cause or effect? J Clin Invest 2004; 114: 23-27.
4. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002; 297: 353-356.
5. Lukiw WJ, Bazan NG. Survival signalling in Alzheimer's disease. Biochem Soc Trans 2006; 34: 1277-1282.
6. Ohyagi Y, Asahara H, Chui DH, Tsuruta Y, Sakae N, Miyoshi K et al. Intracellular Abeta42 activates p53 promoter: A pathway to neurodegeneration in Alzheimer's disease. FASEB J 2005; 19: 255-257.
7. Webster MK, Goya L, Ge Y, Maiyar AC, Firestone GL. Characterization of sgk, a novel member of the serine/threonine protein kinase gene family which is transcriptionally induced by glucocorticoids and serum. Mol Cell Biol 1993; 13: 2031-2040.
8. Lang F, Bohmer C, Palmada M, Seebohm G, Strutz-Seebohm N, Vallon V. (Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms. Physiol Rev 2006; 86 1151-1178.
9. Park J, Leong ML, Buse P, Maiyar AC, Firestone GL, Hemmings BA. Serum and glucocorticoid-inducible kinase (SGK) is a target of the PI 3-kinase-stimulated signaling pathway. EMBO J 1999; 18: 3024-3033.
10. Kobayashi T, Cohen P. Activation of serum- and glucocorticoid-regulated protein kinase by agonists that activate phosphatidylinositide 3-kinase is mediated by 3-phosphoinositide-dependent protein kinase-1 (PDK1) and PDK2. Biochem J 1999; 339: 319-328.
11. Meng F, Yamagiwa Y, Taffetani S, Han J, Patel T. IL-6 activates serum and glucocorticoid kinase via p38alpha mitogen-activated protein kinase pathway. Am J Physiol 2005; 289: C971-C981.
12. Brunet A, Park J, Tran H, Hu LS, Hemmings BA, Greenberg ME. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol Cell Biol 2001; 21 952-965.
13. Leong ML, Maiyar AC, Kim B, O'Keeffe BA, Firestone GL. Expression of the serum-and glucocorticoid-inducible protein kinase, Sgk, is a cell survival response to multiple types of environmental stress stimuli in mammary epithelial cells. J Biol Chem 2003; 278: 5871-5882.
14. Bowman T, Garcia R, Turkson J, Jove R. STATs in oncogenesis. Oncogene 2000; 19: 2474-2488.
15. Horvath CM. STAT proteins and transcriptional responses to extracellular signals. Trends Biochem Sci 2000; 25: 496-502.
16. Ihle JN. The Stat family in cytokine signaling. Curr Opin Cell Biol 2001; 13: 211-217.
17. Decker T, Kovarik P. Serine phosphorylation of STATs. Oncogene 2000; 19: 2628-2637.
18. Battle TE, Frank DA. The role of STATs in apoptosis. Curr Mol Med 2002; 2: 381-392.
19. Kim HS, Lee MS. STAT1 as a key modulator of cell death. Cell Signal 2007; 19: 454-465.
20. Stephanou A, Latchman DS. STAT-1: A novel regulator of apoptosis. Int J Exp Pathol 2003; 84: 239-244.
21. Stephanou A, Brar BK, Scarabelli TM, Jonassen AK, Yellon DM, Marber MS et al. Ischemia-induced STAT-1 expression and activation play a critical role in cardiomyocyte apoptosis. J Biol Chem 2000; 275 10002-10008.
22. Stephanou A, Scarabelli TM, Brar BK, Nakanishi Y, Matsumura M, Knight RA et al. Induction of apoptosis and Fas receptor/Fas ligand expression by ischemia/reperfusion in cardiac myocytes requires serine 727 of the STAT-1 transcription factor but not tyrosine 701. J Biol Chem 2001; 276: 28340-28347.
23. Stephanou A, Brar BK, Knight RA, Latchman DS. Opposing actions of STAT-1 and STAT-3 on the Bcl-2 and Bcl-x promoters. Cell Death Differ 2000; 7: 329-330.
24. Townsend PA, Scarabelli TM, Davidson SM, Knight RA, Latchman DS, Stephanou A. STAT-1 interacts with p53 to enhance DNA damage-induced apoptosis. J Biol Chem 2004; 279: 5811-5820.
25. Timofeeva OA, Plisov S, Evseev AA, Peng S, Jose-Kampfner M, Lovvorn HN et al. Serine-phosphorylated STAT1 is a prosurvival factor in Wilms' tumor pathogenesis. Oncogene 2006; 25: 7555-7564.
26. Patterson SG, Wei S, Chen X, Sallman DA, Gilvary DL, Zhong B et al Novel role of Stat1 in the development of docetaxel resistance in prostate tumor cells. Oncogene 2006; 25: 6113-6122.
27. Mori M, Burgess DL, Gefrides LA, Foreman PJ, Opferman JT, Korsmeyer SJ et al. Expression of apoptosis inhibitor protein Mcl1 linked to neuroprotection in CNS neurons. Cell Death Differ 2004; 11: 1223-1233.
28. Reynolds JE, Yang T, Qian L, Jenkinson JD, Zhou P, Eastman A et al Mcl-1, a member of the Bcl-2 family, delays apoptosis induced by c-Myc overexpression in Chinese hamster ovary cells. Cancer Res 1994; 54: 6348-6352.
29. Kadowaki H, Nishitoh H, Urano F, Sadamitsu C, Matsuzawa A, Takeda K et al. Amyloid beta induces neuronal cell death through ROS-mediated ASK1 activation. Cell Death Differ 2005; 12: 19-24.
30. Aaronson DS, Horvath CM. A road map for those who don't know JAK-STAT. Science 2002; 296: 1653-1655.
31. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995; 270 1326-1331.
32. Hetman M, Gozdz A. Role of extracellular signal regulated kinases 1 and 2 in neuronal survival. Eur J Biochem/FEBS 2004; 271: 2050-2055.
33. Martin D, Salinas M, Lopez-Valdaliso R, Serrano E, Recuero M, Cuadrado A. Effect of the Alzheimer amyloid fragment Abeta(25-35) on Akt/PKB kinase and survival of PC12 cells. J Neurochem 2001; 78: 1000-1008.
34. Zhang L, Cui R, Cheng X, Du J. Antiapoptotic effect of serum and glucocorticoid-inducible protein kinase is mediated by novel mechanism. Cancer Res 2005; 65: 457-464.
35. Lin CL, Chen TF, Chiu MJ, Way TD, Lin JK. Epigallocatechin gallate (EGCG) suppresses beta-amyloid-induced neurotoxicity through inhibiting c-Abl/FE65 nuclear translocation and GSK3beta activation. Neurobiol Aging 2009; 30: 81-92.
36. Ahmad KA, Wang G, Unger G, Slaton J, Ahmed K. Protein kinase CK2 - a key suppressor of apoptosis. Adv Enzyme Regul 2008; 48: 179-187.
37. Chao CC, Chiang CH, Ma YL, Lee EH. Molecular mechanism of the neurotrophic effect of GDNF on DA neurons: Role of protein kinase CK2. Neurobiol Aging 2006; 27: 105-118.
38. Sato N, Kamino K, Tateishi K, Satoh T, Nishiwaki Y, Yoshiiwa A et al Elevated amyloid beta protein(1-40) level induces CREB phosphorylation at serine-133 via p44/42 MAP kinase (Erk1/2)-dependent pathway in rat pheochromocytoma PC12 cells. Biochem Biophys Res Commun 1997; 232: 637-642.
39. Ramsauer K, Sadzak I, Porras A, Pilz A, Nebreda AR, Decker T et al p38 MAPK enhances STAT1-dependent transcription independently of Ser-727 phosphorylation. Proc Natl Acad Sci USA 2002; 99: 12859-12864.
40. Yaffe MB, Leparc GG, Lai J, Obata T, Volinia S, Cantley LC. A motif-based profile scanning approach for genome-wide prediction of signaling pathways. Nat Biotechnol 2001; 19: 348-353.
41. Marin O, Meggio F, Sarno S, Cesaro L, Pagano MA, Pinna LA. Tyrosine versus serine/threonine phosphorylation by protein kinase casein kinase-2. A study with peptide substrates derived from immunophilin Fpr3. J Biol Chem 1999; 274: 29260-29265.
42. Boulton TG, Nye SH, Robbins DJ, Ip NY, Radziejewska E, Morgenbesser SD et al. ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 1991; 65: 663-675.
43. Resende R, Ferreiro E, Pereira C, Resende de Oliveira C. Neurotoxic effect of oligomeric and fibrillar species of amyloid-beta peptide 1-42: involvement of endoplasmic reticulum calcium release in oligomer-induced cell death. Neuroscience 2008; 155: 725-737.
44. Lee HK, Kumar P, Fu Q, Rosen KM, Querfurth HW. The insulin/Akt signaling pathway is targeted by intracellular beta-amyloid. Mol Biol Cell 2009; 20: 1533-1544.
45. Stephan A, Laroche S, Davis S. Generation of aggregated beta-amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits. J Neurosci 2001; 21: 5703-5714.